We are live on ! Find out more
CLMT icon

Calumet Specialty Products

61 hedge funds and large institutions have $230M invested in Calumet Specialty Products in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $12M | Put options by funds: $9.06M

8% more capital invested

Capital invested by funds: $213M → $230M (+$16.6M)

1.06% more ownership

Funds ownership: 20.4%21.46% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

13% less funds holding

Funds holding: 7061 (-9)

35% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 20

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
61
Holders Change
-9
Holders Change %
-12.86%
% of All Funds
0.96%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
7
Increased
13
Reduced
20
Closed
15
Calls
$12M
Puts
$9.06M
Net Calls
+$2.96M
Net Calls Change
-$15.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
76
Barclays
United Kingdom
-$2K -151 Closed

CLMT Hedge Fund Activity: Q1 2022 in Review

61 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q1 2022, worth a combined $230M — up 7.8% from $213M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of CLMT and 7 opened new positions — a net loss of 8 holders — while 20 trimmed existing stakes and 13 added.

The largest buyer was Fidelity Investments, adding an estimated $13.1M. The largest seller was Morgan Stanley, cutting an estimated $3.67M.

  • 61 institutional investors held Calumet Specialty Products (CLMT) as of Q1 2022, down from 70 in Q4 2021.
  • Funds reported $230M of Calumet Specialty Products stock for Q1 2022, up 7.8% quarter-over-quarter.
  • 7 funds opened new Calumet Specialty Products positions in Q1 2022 and 15 closed out, a net change of -8 holders.
  • The largest Calumet Specialty Products buyer in Q1 2022 was Fidelity Investments, an estimated $13.1M added.
  • The largest Calumet Specialty Products seller in Q1 2022 was Morgan Stanley, an estimated $3.67M sold.

Based on aggregated 13F filings for Q1 2022.